Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 19
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
1/14/2009
 
First Published:
5/23/2005
1.
Phase I/II Pilot Study of Flavopiridol in Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
18 and over
NCI
OSU-04100
OSU-2005C0006, NCI-7002, 7002, NCT00112723
Last Modified:
5/13/2008
 
First Published:
3/2/2007
2.
Phase I/II Study of Flavopiridol in Patients With Refractory or Recurrent Mantle Cell Lymphoma or Diffuse Large B-Cell Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
NCI-07-C-0081
NCI-P7040, 7844, NCT00445341
Last Modified:
6/11/2008
 
First Published:
4/23/2004
3.
Phase II Study of Cisplatin and Flavopiridol in Patients With Advanced Ovarian Epithelial or Primary Peritoneal Cancer ( Group 2 closed to accrual as of 3/10/06)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
NCI
MAYO-MC0261
5876, NCI-5876, NCT00083122
Last Modified:
7/26/2007
 
First Published:
11/22/2004
4.
Phase II Study of Flavopiridol in Patients With Previously Treated B-Cell Chronic Lymphocytic Leukemia (CLL) or Prolymphocytic Leukemia Arising from CLL
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
NCI
CLLRC-OSU-0491
7000, NCI-7000, NCT00098371, OSU-0491
5.
Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Pharmaceutical / Industry
EFC6663
NCT00464633
Last Modified:
10/29/2008
 
First Published:
3/10/2008
6.
Phase II Randomized Study of Three Different Induction/Consolidation Chemotherapy Regimens; Carboplatin and Topotecan Hydrochloride Versus Alvocidib, Mitoxantrone Hydrochloride, and Cytarabine Versus Sirolimus, Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 to 70
NCI
ECOG-E1906
E1906, NCT00634244
Last Modified:
11/21/2008
 
First Published:
11/19/2008
7.
Phase II Randomized Study of Two Different Schedules of Alvocidib Followed by Cytarabine and Mitoxantrone Hydrochloride in Patients With Newly Diagnosed Poor-Risk Acute Myeloid Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
JHOC-J0856
J0856, 8237, NCT00795002
Last Modified:
7/26/2007
 
First Published:
10/1/2002
8.
Phase I Study of Flavopiridol, Irinotecan, and Cisplatin in Patients With Advanced Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
NCI
MSKCC-02043
NCI-5700, NCT00046917, 5700
Last Modified:
6/5/2008
 
First Published:
10/25/2003
9.
Phase I Study of Gemcitabine and Flavopiridol in Patients With Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
NCI
DFCI-03110
NCI-6051, NCT00072436, 6051
Last Modified:
7/26/2007
 
First Published:
3/24/2004
10.
Phase I Study of Flavopiridol, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Patients With Advanced Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
NCI
MSKCC-03146
6365, NCI-6365, NCT00080990
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute